Medical Xpress news
Medical Xpress / New biological marker of early-stage Alzheimer's disease uncovered
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and a decline in mental functions. These symptoms are known to arise from an abnormal buildup of proteins known as amyloid ...
Medical Xpress / New yellow fever vaccine matches safety and effectiveness of current shot
Yellow fever is a viral disease that is spread to humans through the bites of infected mosquitoes. The symptoms range from mild fever-like aches and pains to severe liver disease with bleeding, often accompanied by yellowing ...
Medical Xpress / Genetic variants in 1 in 10 people may reduce blood‑sugar response to GLP‑1 diabetes drugs
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who have certain genetic variants, according to a new study by Stanford Medicine ...
Medical Xpress / Shifts in cancer mortality: Place of living increasingly determines where historic drop in cancer mortality reaches
In 1991, the U.S. experienced a significant shift in cancer death rates, as, for the first time, deaths began a steady decline that continues to the present day. Researchers at Mississippi State's Social Science Research ...
Medical Xpress / The brain's default mode network splits into 'sender' and 'receiver' zones, study finds
The default mode network (DMN) is a distributed set of interconnected brain regions that has long been associated with internally oriented cognition, such as remembering the past, thinking about the future, or thinking about ...
Medical Xpress / New drug combination doubles down on Alzheimer's treatments
A new study has found that combining the current medications for Alzheimer's disease with small molecules derived from micronutrients found in grapes, berries, peanuts and turmeric is a safer and more effective way to treat ...
Medical Xpress / Experimental drug cuts Parkinson's-linked protein up to 60% in early trial
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a first-in-human clinical trial, according to a study published in Nature Medicine. The drug, known as ...
Medical Xpress / Molecular maps reveal how allergic reactions work and a new way to block them
Allergy affects more than one billion people worldwide—and the number is rising. For many, it means mild symptoms such as itching and a runny nose. For others, it can develop into life-threatening reactions. Now, two new ...
Medical Xpress / Researchers map prostate immune niches, showing T cells persist months in mice
More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell weaponry we might use to save lives.
Medical Xpress / Skin protein K16 found to control inflammation in stressed skin
Keratin is the fibrous, waterproof protein that builds everything from our hair and nails to a rhino's horn. However, a tiny glitch in it can have problematic outcomes. A new study has found that changes in a keratin gene ...
Medical Xpress / AI scans 400,000 Reddit posts to flag overlooked GLP-1 side effects
By using AI to analyze more than 400,000 Reddit posts, Penn researchers have identified patient-reported symptoms associated with GLP-1s, the popular weight-loss and diabetes drugs semaglutide and tirzepatide, that may not ...
Medical Xpress / Women's immune systems show bigger age-related changes than men's, study reveals
Statistics show clear differences in the population's immune system according to sex: men are more susceptible to infections and cancers, while women have stronger immune responses, which translate, for example, into better ...
